

Envarsus XR is a once-daily extended-release tacrolimus tablet used to prevent kidney transplant rejection. Learn about uses, dosing, cost, and more.
Envarsus XR is a once-daily, extended-release tablet form of Tacrolimus, a calcineurin inhibitor immunosuppressant used to prevent organ rejection in kidney transplant patients.
It's manufactured by Veloxis Pharmaceuticals and was approved by the FDA for use in kidney transplant recipients. The active ingredient — Tacrolimus — is the same one found in Prograf (immediate-release) and Astagraf XL (extended-release capsules), but Envarsus XR uses a proprietary delivery technology called MeltDose that changes how the drug is absorbed. This means these formulations are not interchangeable — you can't simply swap one for another without your doctor's guidance.
Envarsus XR is not a controlled substance.
Envarsus XR is FDA-approved for two specific uses:
In both cases, Envarsus XR is always used alongside other immunosuppressant medications — it's not a standalone treatment.
While not FDA-approved for these conditions, Tacrolimus (the active ingredient) is sometimes used off-label for:
Off-label use should only happen under close medical supervision.
Envarsus XR is taken once daily, in the morning, on an empty stomach — at least 1 hour before or 2 hours after a meal. This is important because food (especially high-fat meals) affects how the drug is absorbed.
Key dosing details:
Your doctor will adjust your dose based on Tacrolimus trough levels measured through regular blood tests. These levels are critical — too high and you risk toxicity; too low and you risk rejection.
For a full list of things to watch out for, see our guide on Envarsus XR drug interactions.
You should not take Envarsus XR if you have a known allergy (hypersensitivity) to Tacrolimus or any of the inactive ingredients in the tablet.
Envarsus XR also carries a boxed warning about the increased risk of serious infections and malignancies (including lymphoma). Your transplant team will weigh these risks against the benefits of preventing organ rejection.
Special caution is needed for:
For more on side effects and risks, read our detailed guide on Envarsus XR side effects.
Envarsus XR is a brand-name medication with no generic equivalent. Cash prices typically range from $270 to $1,500+ per month, depending on your dose and quantity.
Here's what you should know about coverage and savings:
For a full breakdown of savings options, see our guide on how to save money on Envarsus XR.
Envarsus XR is a critical medication for kidney transplant patients — offering the convenience of once-daily dosing with the proven anti-rejection power of Tacrolimus. Understanding how to take it properly, what side effects to watch for, and how to manage costs can make a big difference in your transplant journey.
If you're having trouble finding Envarsus XR at your pharmacy, Medfinder can help you check stock near you. And if you need a prescriber, check out our guide on finding a doctor who prescribes Envarsus XR.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.